EMAPALUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 17:11:21 GMT 2023` Edited by `admin` on `Sat Dec 16 17:11:21 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	3S252O2Z4X
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

EMAPALUMAB

Official Name

English

EMAPALUMAB [USAN]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERFERON .GAMMA.) (HUMAN MONOCLONAL NI-0501 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL NI-0501 LIGHT CHAIN, DIMER

Common Name

English

IMMUNOGLOBULIN G1-LAMBDA1, ANTI-(HOMO SAPIENS IFNG (INTERFERON GAMMA, IFN GAMMA)), HOMO SAPIENS MONOCLONAL ANTIBODY

Systematic Name

English

EMAPALUMAB [JAN]

Common Name

English

NI-0501

Code

English

EMAPALUMAB [MI]

Common Name

English

emapalumab [INN]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

766720

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

FDA ORPHAN DRUG

302910

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

WHO-ATC

L04AA39

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

Code System Code Type Description

LACTMED

Emapalumab

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

PRIMARY

WIKIPEDIA

Emapalumab

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

PRIMARY

USAN

DE-170

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

PRIMARY

RXCUI

2104604

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

PRIMARY

DRUG CENTRAL

5320

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

PRIMARY

RXCUI

2104603

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

ALTERNATIVE

DAILYMED

3S252O2Z4X

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

PRIMARY

CAS

1709815-23-5

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

PRIMARY

MERCK INDEX

m12181

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

PRIMARY

INN

10319

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

PRIMARY

DRUG BANK

DB14724

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

PRIMARY

NCI_THESAURUS

C127123

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

PRIMARY

FDA UNII

3S252O2Z4X

Created by admin on Sat Dec 16 17:11:22 GMT 2023 , Edited by admin on Sat Dec 16 17:11:22 GMT 2023

PRIMARY

From	To
1_22	1_96
1_150	1_206
1_226	3_216
1_232	2_232
1_235	2_235
1_267	1_327
1_373	1_431
2_22	2_96
2_150	2_206
2_226	4_216
2_267	2_327
2_373	2_431
3_22	3_91
3_139	3_198
4_22	4_91
4_139	4_198

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_303
N	2_303

Related Record Type Details

EMAPALUMAB-LZSG

INNOVATOR->PARENT

Amount:

EMAPALUMAB-LZSG

SUB_CONCEPT->SUBSTANCE

Amount:


					P050J5FWC5

INTERFERON GAMMA

TARGET -> INHIBITOR

Related Record Type Details


					3S252O2Z4X

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL